컨텐츠 내용을 수정할 수 있습니다
Sleep is regulated by two processes: a homeostatic sleep drive that builds with time awake (adenosine accumulation) and a circadian rhythm set by the suprachiasmatic nucleus and entrained by light, which controls melatonin release. Normal sleep cycles about every 90 minutes through non-REM stages N1–N3 (N3 = deep, restorative slow-wave sleep) and REM sleep (dreaming, muscle atonia, memory consolidation). Wakefulness is supported by orexin (hypocretin), histamine, and other arousal systems.
Poor sleep worsens depression, anxiety, psychosis, mania, pain, and substance use, and insomnia is a risk factor for suicide. Sleep disturbance is often an early sign of relapse in mood and psychotic disorders.
| Disorder | Key features |
|---|---|
| Insomnia disorder | Difficulty initiating or maintaining sleep or early waking, with daytime impairment, at least 3 nights a week for at least 3 months, despite adequate opportunity to sleep |
| Hypersomnolence disorder | Excessive sleepiness despite at least 7 hours of main sleep |
| Narcolepsy | Recurrent irresistible sleep attacks at least 3 times a week for 3 months, with cataplexy (sudden loss of muscle tone triggered by strong emotion such as laughter), hypocretin deficiency, or characteristic sleep study findings. Classic tetrad: excessive daytime sleepiness, cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations |
| Obstructive sleep apnea hypopnea | Repeated upper-airway collapse during sleep; snoring, witnessed apneas, gasping, daytime sleepiness |
| Central sleep apnea, sleep-related hypoventilation | Reduced respiratory drive (e.g., heart failure, opioids) |
| Circadian rhythm sleep-wake disorders | Delayed sleep phase (falls asleep and wakes much later than socially required — commonly 2 hours or more; common in adolescents), advanced phase (older adults), irregular, non-24-hour, shift work type |
| Non-REM sleep arousal disorders | Sleepwalking and sleep terrors in the first third of the night; little recall |
| Nightmare disorder | Repeated vivid, distressing dreams with full alertness on waking |
| REM sleep behavior disorder (RBD) | Loss of normal REM atonia → acting out dreams (punching, kicking, falling out of bed); strong link to later Parkinson disease or Lewy body dementia |
| Restless legs syndrome (RLS) | Urge to move the legs with uncomfortable sensations, worse at rest and in the evening, relieved by movement; associated with iron deficiency, pregnancy, kidney failure |
| Substance/medication-induced sleep disorder | Alcohol, stimulants, caffeine, withdrawal |
Periodic limb movement disorder (classified in sleep medicine rather than DSM-5-TR) involves repetitive, stereotyped limb movements during sleep, usually unnoticed by the person but disturbing sleep.
| Tool/test | Use |
|---|---|
| Epworth Sleepiness Scale | Daytime sleepiness; score above 10 suggests excessive sleepiness |
| Insomnia Severity Index | Insomnia severity |
| STOP-BANG | OSA screening: Snoring, Tiredness, Observed apnea, blood Pressure, BMI over 35, Age over 50, Neck circumference large, male Gender |
| Polysomnography | Gold standard for OSA, RBD (REM without atonia), and periodic limb movements |
| Home sleep apnea test | Uncomplicated suspected moderate to severe OSA |
| Apnea-hypopnea index (AHI) | Events per hour: 5–14 mild, 15–29 moderate, 30 or more severe |
| Multiple Sleep Latency Test | Narcolepsy: mean sleep latency 8 minutes or less with 2 or more sleep-onset REM periods |
| Actigraphy | Circadian rhythm disorders |
| Serum ferritin and iron studies | RLS — iron therapy when ferritin is 75 ng/mL (75 µg/L) or below or transferrin saturation is under 20% |
| Drug class | Examples | Safety points |
|---|---|---|
| Z-drugs (benzodiazepine receptor agonists) | zolpidem, eszopiclone, zaleplon | Boxed warning: complex sleep behaviors (sleepwalking, sleep driving) — stop if they occur; next-day impairment (lower zolpidem doses for women); take only with 7–8 hours available for sleep; falls in older adults |
| Benzodiazepines | temazepam, lorazepam | Dependence, withdrawal, respiratory depression with opioids or alcohol (boxed warning); falls and cognitive impairment in older adults; never stop abruptly after long-term use — taper |
| Orexin receptor antagonists | suvorexant, lemborexant, daridorexant | Next-day drowsiness; contraindicated in narcolepsy |
| Melatonin receptor agonist | ramelteon | Sleep onset insomnia; low abuse potential |
| Tricyclic at very low dose | doxepin 3–6 mg | Sleep maintenance; anticholinergic effects at higher doses |
| Sedating antihistamines | diphenhydramine | Not recommended — anticholinergic, confusion and urinary retention in older adults |
Restless legs syndrome (AASM 2024 update)
Listed in priority order.
CPAP — use every night and for naps; clean the mask and tubing regularly; bring the device to the hospital
| Complication | What to watch for |
|---|---|
| Respiratory depression | Sedatives combined with opioids or alcohol; untreated OSA |
| Complex sleep behaviors | Sleep driving or walking after Z-drugs |
| Falls and hip fracture | Older adults on hypnotics |
| Drowsy-driving crashes | Narcolepsy, untreated OSA, shift work |
| Cardiovascular disease | Untreated OSA → hypertension, atrial fibrillation, stroke, heart failure |
| Suicide risk | Persistent insomnia, nightmares with depression or PTSD |
| Neurodegenerative disease | RBD may precede Parkinson disease or Lewy body dementia |
| Benzodiazepine withdrawal | Anxiety, tremor, seizures after abrupt stop |
다음 이론을 계속 학습하려면 로그인하세요.
로그인하고 계속 학습필기노트, 하이라이터, 메모는 잘 쓰고 있어?
내보내줘운영진이 검토할게요!
마이페이지에서 차단한 회원을 관리할 수 있어요.